Latest 30 News in the Life Sciences Industry
PR Newswire Association LLC.
NUH RECOGNISED AMONG WORLD'S GREENEST HOSPITALS; ONLY SINGAPORE HOSPITAL AWARDED HIGHEST DISTINCTION
11 Aug 2026
PR Newswire Association LLC.
Experts at Apollo Hospital, Bilaspur, Remove Esophagus Cancer, Create A New Food Passage Using Stomach
06 Aug 2026
PR Newswire Association LLC.
Cipla Health's new 'W.H.O. hai toh woh ORS hai' campaign highlights the importance of knowing the correct ORS
30 Jul 2026
PR Newswire Association LLC.
AbbVie Announces Availability of ELAHERE® (mirvetuximab soravtansine) in Singapore for the Treatment of Platinum-Resistant Ovarian Cancer
29 Jul 2026
PR Newswire Association LLC.
Apollo Hospitals Pune Performs Its First Robotic-Assisted Coronary Artery Bypass Surgery
29 Jul 2026
PR Newswire Association LLC.
Glenmark Pharmaceuticals Inc., USA launches Sugammadex Injection, 200 mg/2 mL (100 mg/mL) and 500 mg/5 mL (100 mg/mL) Single-Dose Vials
28 Jul 2026
PR Newswire Association LLC.
Teleradiology Market to Reach USD 14.67 Billion by 2031 Growing Demand for Remote Diagnostic Services and AI-Enabled Imaging Solutions Accelerates Market Expansion, Says Mordor Intelligence
23 Jul 2026
PR Newswire Association LLC.
The Silent Sleep Crisis: Apollo Experts Warn That 80-90% of Sleep Apnoea Cases Go Undiagnosed
16 Jul 2026
PR Newswire Association LLC.
AbbVie Employees Across Asia Unite Through Week of Possibilities by Serving and Supporting Communities
13 Jul 2026
PR Newswire Association LLC.
Five Trends That Will Shape the Future of Obesity Care in India: Ajanta Pharma Shares Its Perspective on the Next Decade of Metabolic Health
09 Jul 2026
PR Newswire Association LLC.
Guwahati Gets a Life-Saving Heart Breakthrough: Apollo Hospitals Performs Northeast India's First LAA Closure
09 Jul 2026
GlobeNewswire
Novartis agrees to acquire Myricx Bio, advancing next-generation antibody-drug conjugate innovation with a novel NMTi payload, expanding options for cancer patients
06 Jul 2026
PR Newswire Association LLC.
Omnigel strengthens its portfolio with the introduction of Omnigel Maxstrong
06 Jul 2026
PR Newswire Association LLC.
Citric Acid Market Size to Reach USD 4.81 Billion by 2031 as Clean-Label Foods and Sustainable Detergents Fuel Global Demand, Mordor Intelligence Report
06 Jul 2026
GlobeNewswire
Travel Fatigue Treatments Gain Traction as Summer Travel Increases, Says Prana IV Therapy
30 Jun 2026
PR Newswire Association LLC.
Apollo Hospitals, Bangalore Becomes First in India to Receive Dual American Heart Association Certification for Stroke and Chest Pain Care
30 Jun 2026
GlobeNewswire
FDA approves Pluvicto for PSMA+ metastatic hormone-sensitive prostate cancer (mHSPC), advancing potential new standard of care across metastatic disease
31 Jul 2026
GlobeNewswire
Novartis delivered sales growth in Q2 and further advanced the pipeline; Full-year guidance reaffirmed
21 Jul 2026
GlobeNewswire
Novartis Fabhalta® (iptacopan) receives FDA traditional approval as first and only complement inhibitor to significantly slow kidney function decline in primary IgAN
17 Jul 2026
GlobeNewswire
Organic & Natural Health Association and India's SHEFEXIL Establish Strategic Partnership to Strengthen U.S.-India Supply Chain
14 Jul 2026
GlobeNewswire
Novartis receives European Commission approval for Itvisma® for spinal muscular atrophy (SMA)
02 Jul 2026
GlobeNewswire
Novartis RemIND data at EAACI show Rhapsido® potential as first targeted therapy for chronic inducible urticaria (CIndU)
12 Jun 2026
GlobeNewswire
Novartis delpacibart braxlosiran (del-brax) Phase I/II study in facioscapulohumeral muscular dystrophy (FSHD) meets primary biomarker endpoint
11 Jun 2026
GlobeNewswire
Novartis to highlight Rhapsido® data across multiple immune-mediated diseases at EAACI Congress 2026
08 Jun 2026
GlobeNewswire
Novartis IgAN data in The Lancet show clinically meaningful slowing of kidney function decline with Vanrafia® over 2.5 years
04 Jun 2026
GlobeNewswire
Novartis Cosentyx® PMR data in New England Journal of Medicine showed sustained remission vs placebo in twice as many patients
03 Jun 2026
GlobeNewswire
Novartis data at EULAR 2026 demonstrates momentum for broad immunology portfolio for complex, high unmet need diseases
01 Jun 2026
Upcoming Events All Events
- August 2026
- Online: Biotechgate Digital Partnering August 2026
- September 2026
- Marina Bay Sands: Asia Bio Partnering Forum
- Zurich: HealthVC Summit